Introducing our Monoclonal Antibodies for Cell and Gene Therapy (CGT) studies: precision-engineered tools designed to enhance the specificity and reliability of your CGT research. With exceptional targeting accuracy, consistent performance, and versatile applications, these antibodies are ideal for target identification, gene editing monitoring, and therapeutic development. Supported by rigorous quality control and expert resources, they are essential for advancing your CGT endeavors efficiently and effectively.